Zhendong Pharmacy(300158.SZ)

Last Updated 00:00:00
longbridge loading

00:35 ETSky Labs bringt „CART ON" auf den Markt, die weltweit erste ringförmige, tragbare Blutdrucküberwachungslösung für Krankenhausabteilungen

prnewswire·
SH
513700
-0.53%
US
XBI
+3.88%
SH
512010
-0.57%
prnewswire·
SH
513700
-0.53%
US
XBI
+3.88%
SH
512010
-0.57%

Zhendong Pharmacy established a refined wall-breaking decoction pieces technology company

Zhitong·
SZ
300158
-1.75%
Zhitong·
SZ
300158
-1.75%

Zhendong Pharmacy released its performance for the first three quarters, with a net profit attributable to the parent company of 20.3641 million yuan, a decrease of 49.25%

Zhitong·
SZ
300158
-1.75%
Zhitong·
SZ
300158
-1.75%

Innovative drug concept stocks fell in the afternoon, with Staidson BioPharm down over 10%

Zhitong·
SZ
002940
-4.69%
SZ
300158
-1.75%
SZ
300204
-0.34%
Zhitong·
SZ
002940
-4.69%
SZ
300158
-1.75%
SZ
300204
-0.34%

Zhendong Pharmacy: Adjusting the upper limit of the repurchase price to RMB 11.40 per share

Zhitong·
SZ
300158
-1.75%
Zhitong·
SZ
300158
-1.75%

The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHARMACEUTICAL, Zhendong Pharmacy, ZHONGSHENGYAOYE, Hansen Pharmaceutical, and ENWEI PHARMACEUTICAL following suit

Zhitong·
SZ
301331
-0.30%
SZ
002873
-1.43%
SZ
300158
-1.75%
Zhitong·
SZ
301331
-0.30%
SZ
002873
-1.43%
SZ
300158
-1.75%

The traditional Chinese medicine concept continues to strengthen, with Layn hitting the daily limit, and companies such as Zhongsheng Pharmaceutical, Kanion Pharmaceutical, JINGXIN, Zhendong Pharmacy, CONBA, and Chase Sun also rising

Zhitong·
SH
600572
-1.64%
SZ
300026
-1.50%
SZ
002166
+1.13%
Zhitong·
SH
600572
-1.64%
SZ
300026
-1.50%
SZ
002166
+1.13%

A-share pharmaceutical stocks continue to adjust, CheezhengTTM approaches the limit down, and multiple stocks such as Xintian Pharmaceutical, Hanyu Pharmaceutical, Guilin Sanjin, Foci Pharmaceutical, YIBAI PHARMACEUTICAL, Zhendong Pharmacy, and Cosunter have fallen over 5%

Wallstreetcn·
SZ
300158
-1.75%
SZ
002287
-0.54%
SH
600594
-2.81%
Wallstreetcn·
SZ
300158
-1.75%
SZ
002287
-0.54%
SH
600594
-2.81%

Zhendong Pharmacy: The company has no drugs available for the treatment of Chikungunya virus

Zhitong·
SZ
300158
-1.75%
Zhitong·
SZ
300158
-1.75%

Zhendong Pharmacy: Vaginal Lactobacillus Dual Live Bacteria Capsules Achieve Primary Research Endpoint

Zhitong·
SZ
300158
-1.75%
Zhitong·
SZ
300158
-1.75%
© 2026 Longbridge｜Disclaimer